Harsaul Foundation - Oct 18, 2023 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
10%+ Owner
Signature
/s/CAMILO A. MENDEZ CHONG, Harsaul Foundation, by Dirserv Inc., Foundation Council Member, By: Camilo A. Mendez Chong
Stock symbol
RVLP
Transactions as of
Oct 18, 2023
Transactions value $
-$221,031
Form type
4
Date filed
10/20/2023, 03:59 PM
Next filing
Oct 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Sale -$221K -3.42M -15.22% $0.06 19.1M Oct 18, 2023 By Self as indirect owner of Altchem Limited F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a volume weighted average price. These shares were sold in multiple transactions at prices ranging from $0.0600 to $0.0678, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited.